Table 4 Comparisons of clinical parameters, glucocorticoid dosage, costs, and renal damage and recurrence rate between the two groups [cases(%),−x ± s]
Conventional group(n = 30) | HP group(n = 30) | P value | |
|---|---|---|---|
Age(years) | 7.40 ± 2.97 | 7.77 ± 3.40 | 0.658 |
Gender(M/F) | 17/13 | 20/10 | 0.596 |
GI bleeding | 25(83) | 25(83) | 1.000 |
Persistent abdominal pain | 5(17) | 5(17) | 1.000 |
intussusception | 1(3) | 3(10) | 0.612 |
Intestinal obstruction | 0(0) | 1(3) | 1.000 |
Intestinal perforation | 1(3) | 1(3) | 1.000 |
Acute pancreatitis | 1(3) | 1(3) | 1.000 |
Arthralgia | 13(43) | 11(37) | 0.792 |
WBC(×109/L) | 14.75 ± 6.12 | 14.66 ± 6.03 | 0.953 |
CRP(mg/L) | 9.16 ± 9.44 | 12.93 ± 16.90 | 0.292 |
ALB (g/L) | 40.46 ± 6.40 | 38.86 ± 6.75 | 0.351 |
Scr(μmol/L) | 27.49 ± 8.68 | 31.02 ± 10.35 | 0.157 |
IgA(g/L) | 1.84 ± 0.68 | 2.02 ± 0.62 | 0.286 |
C3(g/L) | 1.08 ± 0.29 | 1.04 ± 0.23 | 0.496 |
Fib(g/L) | 3.25 ± 2.69 | 2.46 ± 0.64 | 0.125 |
GI syndromes disappeared | 13(43) | 22(73) | 0.035 |
Time for rash disappearance(d) | 8.10 ± 3.54 | 6.57 ± 2.18 | 0.048 |
Time for digestive tract symptom disappearance(d) | 9.00 ± 4.35 | 6.33 ± 4.51 | 0.023 |
Daily glucocorticoid dosage (mg/kg) | 10.19 ± 5.19 | 4.74 ± 1.44 | 0.000 |
Hospital Costs(thousand yuan) | 17.23 ± 8.60 | 28.40 ± 11.98 | 0.000 |
Length of stay (d) | 16.5 ± 6.5 | 17.9 ± 6.5 | 0.435 |
Hematuria and/or proteinuria | 23(77) | 11(37) | 0.004 |
Recurrence of rah | 11(37) | 6(20) | 0.252 |
Recurrence of abdominal pain | 6(20) | 5(17) | 1.000 |